NCT00330083View on ClinicalTrials.gov

Safety of ALK Ragweed Tablet

PHASE1CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

May 31, 2006

Conditions

Allergy

Interventions

BIOLOGICAL

ALK Ragweed Tablet

Trial Locations (1)

78229

Healthcare Discoveries Inc., San Antonio

All Listed Sponsors

lead

ALK-Abelló A/S

INDUSTRY

NCT00330083 - Safety of ALK Ragweed Tablet | Biotech Hunter | Biotech Hunter